This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 673827
Submitted by lobbyist on: August 24, 2017 05:51:15 AM
Accepted by Registrar on: August 24, 2017 09:33:14 AM
Designated Filer Information
| Keast, Monty |
| 20 Bay Street Suite 1520 | |
|
Toronto, ON, M5J 2N8
|
647-790-1602 |
| Canada |
Organization Information
| Vertex Pharmaceuticals (Canada) Inc. |
| Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines to treat people with serious diseases. Vertex has a commercial office in Ontario and a research and development site in Quebec. |
| 20 Bay Street Suite 1520 | |
|
Toronto, ON, M5J 2N8
|
647-790-1602 |
| Canada |
Relevant Affiliates
Type:
| Business Name | Mailing Address | Contact Information |
|---|---|---|
| Vertex Pharmaceuticals Inc. |
50 Northern Avenue
Boston, MA 02210 United States of America |
Phone: |
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
| August 24, 2017 | |
| February 24, 2018 |
Organization's In-House Lobbyists
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
The listing and reimbursement of Health Canada approved Vertex medicines for eligible patients in British Columbia
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Staff of Minister | Premier | August 24, 2017 | |
| Staff of Minister | Minister of Health | August 24, 2017 | |
| Public Agency | Health | August 24, 2017 |